Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Lantus Dosing for Pancreagenic Diabetes Patient Receiving Dexamethasone

Rationale for Dose Adjustment

  • Dexamethasone at 8 mg significantly increases blood glucose levels, with effects persisting for at least 24 hours after administration 3
  • Steroid-induced hyperglycemia is characterized by afternoon and evening hyperglycemia that can persist for 24 hours or longer after administration 1, 2

Specific Dosing Recommendations

  • For a patient with pancreagenic diabetes on 24 units of Lantus receiving 8 mg dexamethasone, the Lantus dose should be increased to 36 units (150% of baseline) on the day of dexamethasone administration and maintained at this higher dose for the day after, then gradually tapered back to baseline as blood glucose normalizes 1, 2
  • Day of dexamethasone administration: Increase Lantus from 24 units to 36 units (150% of baseline dose) 1, 2
  • Day after dexamethasone administration: Maintain the increased dose of 36 units 1, 2
  • Subsequent days: Monitor blood glucose and gradually reduce Lantus back to baseline 24 units as glucose levels normalize 2

Monitoring Recommendations

  • Check blood glucose every 4-6 hours while the patient is on dexamethasone 4
  • Pay particular attention to afternoon and evening glucose levels, as steroid-induced hyperglycemia tends to be more pronounced during these times 1, 2
  • If blood glucose exceeds a high level despite the increased basal insulin, consider adding correction doses of rapid-acting insulin 4

Special Considerations for Pancreagenic Diabetes

  • Patients with pancreagenic diabetes may have more unpredictable insulin requirements due to variable beta-cell function 4
  • More frequent glucose monitoring may be necessary to ensure appropriate insulin dosing 4
  • Consider the patient's nutritional status and oral intake when adjusting insulin doses 4